BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34379360)

  • 1. Impact of PRR11 Expression on Prognosis in Pancreatic Cancer Patients with Diabetes.
    Yu X; Wang Y; Zhuang Y; Mao X; Jia Y
    Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38843413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer.
    Kang SH; Cho J; Jeong H; Kwon SY
    J Breast Cancer; 2018 Sep; 21(3):288-296. PubMed ID: 30275857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MZF1 alleviates oxidative stress and apoptosis induced by rotenone in SH-SY5Y cells by promoting RBM3 transcription.
    Zhang J; Chai W; Xiang Z; Zhou X; Zhang P
    J Toxicol Sci; 2021; 46(10):477-486. PubMed ID: 34602532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma.
    Wen J; Wan L; Dong X
    PLoS One; 2024; 19(3):e0299720. PubMed ID: 38427643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
    Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
    Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Functions of RNA-Binding Motif Protein 3 (RBM3): Clues in Hypothermia, Cancer Biology and Apoptosis.
    Al-Astal HI; Massad M; AlMatar M; Ekal H
    Protein Pept Lett; 2016; 23(9):828-35. PubMed ID: 27364162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRR11 in Malignancies: Biological Activities and Targeted Therapies.
    Han W; Chen L
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
    Olsson Hau S; Wahlin S; Cervin S; Falk V; Nodin B; Elebro J; Eberhard J; Moran B; Gallagher WM; Karnevi E; Jirström K
    J Pathol Clin Res; 2022 Jan; 8(1):65-77. PubMed ID: 34379360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.
    Karnevi E; Dror LB; Mardinoglu A; Elebro J; Heby M; Olofsson SE; Nodin B; Eberhard J; Gallagher W; Uhlén M; Jirström K
    Oncotarget; 2018 Jan; 9(5):6188-6200. PubMed ID: 29464064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
    Sun Y; Xu D; Zhang C; Wang Y; Zhang L; Qiao D; Bu Y; Zhang Y
    Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
    Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
    Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.
    Ehlén A; Brennan DJ; Nodin B; O'Connor DP; Eberhard J; Alvarado-Kristensson M; Jeffrey IB; Manjer J; Brändstedt J; Uhlén M; Pontén F; Jirström K
    J Transl Med; 2010 Aug; 8():78. PubMed ID: 20727170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrier-to-autointegration factor: a first responder for repair of nuclear ruptures.
    Halfmann CT; Roux KJ
    Cell Cycle; 2021 Apr; 20(7):647-660. PubMed ID: 33678126
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.